Amanote Research
Register
Sign In
Bosentan Is Effective Against Digital Ulcerations and Hyperkeratosis in Systemic Sclerosis
Acta Dermato-Venereologica
- Sweden
doi 10.2340/00015555-1138
Full Text
Open PDF
Abstract
Available in
full text
Categories
Dermatology
Medicine
Date
January 1, 2011
Authors
Z Kurgyis
R Varga
I Sick
M Lang
T Ruzicka
M Sárdy
Publisher
Acta Dermato-Venereologica
Related search
Bosentan and Macitentan Prevent the Endothelial-To-Mesenchymal Transition (EndoMT) in Systemic Sclerosis: In Vitro Study
Arthritis Research & Therapy
Exocrine Pancreatic Function Is Preserved in Systemic Sclerosis
Arthritis Research & Therapy
Clinical Association of Serum Interleukin-17 Levels in Systemic Sclerosis: Is Systemic Sclerosis a Th17 Disease?
Journal of Dermatological Science
Dermatology
Biochemistry
Molecular Biology
Treprostinil for the Treatment of Severe Digital Necrosis in Systemic Sclerosis
Vascular Medicine
Medicine
Cardiovascular Medicine
Cardiology
Risk of Digital Ulcers Occurrence in Systemic Sclerosis: A Cross-Sectional Study
Advances in Rheumatology
Rheumatology
İdiopathic Palmoplantar Filiform Hyperkeratosis Succesfully Treated With Systemic Isotretinoin
Turkderm Deri Hastaliklari ve Frengi Arsivi
Dermatology
Infectious Diseases
Molecular Subtypes of Systemic Sclerosis in Association With Anti-Centromere Antibodies and Digital Ulcers
Genes and Immunity
Immunology
Genetics
Effects of Botulinum Toxin Injection on Systemic Sclerosis-Related Digital Ulcers
Korean Journal of Internal Medicine
Internal Medicine
Digital Ulcers in Systemic Sclerosis: Their Epidemiology, Clinical Characteristics, and Associated Clinical and Economic Burden
Arthritis Research & Therapy
